Cargando...
Romera I, Artime E, Ihle K, Diaz-Cerezo S, Rubio de-Santos M, de Prado A, Cebrian-Cuenca A, Conget I. A Retrospective Observational Study Examining the Generalizability of Glucagon-Like Peptide 1 Receptor Agonist Cardiovascular Outcome Trials to the Real-World Population with Type 2 Diabetes in Spain: The REPRESENT Study. Adv Ther. 2022 Aug;39(8):3589-3601. doi: 10.1007/s12325-022-02196-0. Epub 2022 Jun 11. PubMed PMID: 35689162.
AÑO: 2022; IF: 3.8
Fabbro E, Arnau Sanchez J, Del Pilar Lopez Acuna M, Hukelova H, Alcaraz Quinonero M, Pantosti A, Busani L. Where we are in the fight against Antimicrobial Resistance and Healthcare-Associated Infections. The opinion of the stakeholders of the European Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI). Ann Ist Super Sanita. 2022 Jul-Sep;58(3):204-212. doi: 10.4415/ANN_22_03_10. PubMed PMID: 36128970.
AÑO: 2022; IF: 1.1
Martínez-Nicolás I., Arenas Castañeda P.E., Molina-Pizarro C.A., Franco A.R., Maya-Hernández C., Barahona I., Martínez-Alés G., Bisquert F.A., Baca-García E., Barrigón M.L. Impact of Depression on Anxiety, Well-being, and Suicidality in Mexican Adolescent and Young Adult Students from Mexico City: A Mental Health Screening Using Smartphones. Journal of Clinical Psychiatry. May 2022. 83. 10.4088/JCP.20m13806
AÑO: 2022; IF: 5.3
Avila-Gandia V, Sanchez-Macarro M, Luque-Rubia A, Garcia-Sanchez E, Canovas F, Lopez-Santiago A, Lopez-Roman FJ. High versus Low-Moderate Intensity Exercise Training Program as an Adjunct to Antihypertensive Medication: A Pilot Clinical Study. J Pers Med. 2021 Apr 10;11(4):291. doi: 10.3390/jpm11040291. PubMed PMID: 33920194; PubMed Central PMCID: PMC8069909.
AÑO: 2021; IF: 3.508
Victoria-Montesinos D, Abellan Ruiz MS, Luque Rubia AJ, Guillen Martinez D, Perez-Pinero S, Sanchez Macarro M, Garcia-Munoz AM, Canovas Garcia F, Castillo Sanchez J, Lopez-Roman FJ. Effectiveness of Consumption of a Combination of Citrus Fruit Flavonoids and Olive Leaf Polyphenols to Reduce Oxidation of Low-Density Lipoprotein in Treatment-Naive Cardiovascular Risk Subjects: A Randomized Double-Blind Controlled Study. Antioxidants (Basel). 2021 Apr 11;10(4):589. doi: 10.3390/antiox10040589. PubMed PMID: 33920476; PubMed Central PMCID: PMC8069525.
AÑO: 2021; IF: 7.675
< AnteriorSiguiente >